HOLLIE TOUCHET: Open Payments
NPI 1598305260 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 76 payments from 16 companies in 2025. Trend: 2023 $787 · 2024 $1,210 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $226 |
| Amgen Inc. | 13 | $164 |
| AstraZeneca Pharmaceuticals LP | 9 | $153 |
| Lilly USA, LLC | 12 | $149 |
| PFIZER INC. | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Edwards Lifesciences Corporation | 2 | $46 |
| Ardelyx, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 6 | $27 |
Products named: Wegovy, MOUNJARO, AIRSUPRA, EVENITY, Ozempic, PREVNAR 20, OTEZLA, REXULTI.
Industry payments across LA — which companies pay providers there.
